Therapeutic use of anti-tweak receptor antibodies

Details for Australian Patent Application No. 2008284025 (hide)

Owner Facet Biotech Corporation

Inventors Culp, Patricia

Agent Davies Collison Cave

Pub. Number AU-A-2008284025

PCT Pub. Number WO2009/020933

Priority 60/953,745 03.08.07 US; 61/123,623 09.04.08 US

Filing date 4 August 2008

Wipo publication date 12 February 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

11 February 2010 PCT application entered the National Phase

  PCT publication WO2009/020933 Priority application(s): WO2009/020933

1 April 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 10 Mar 2010

3 February 2011 Alteration of Name

  The name of the applicant has been altered to Abbott Biotherapeutics Corp. 2009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008284042-Vestibular stimulation apparatus and associated methods of use

2008284024-In-situ hybridization to detect RNA and DNA markers